Weekly Recap | 3SBIO -4.75%, consensus target above spotWeekly Review·Nov 14, 2026 at 05:15 AM01530-1.58%
Citic Securities Sticks to Its Buy Rating for 3SBio (TRSBF)Tip Ranks·Nov 13, 2026 at 05:15 AM01530-1.58%
SanRex proposes to acquire Frontage Holdings for HKD 2.370 per sharePUBT·Nov 9, 2026 at 10:58 AM01530-1.58%
Weekly Recap | 3SBIO +10.96%, consensus target above spotWeekly Review·Nov 7, 2026 at 09:34 AM01530-1.58%
Chinese Drug Licensing Boom Seen Intact as Proposed US Curbs Cloud Equity DealsYicai·Oct 27, 2026 at 10:54 AM01276-2.62%01530-1.58%
3SBIO drops 5% as US plans curbs on China biotech investmentMarket Movers·Oct 27, 2026 at 02:54 AM01530-1.58%
SSY Group falls 4% to 52-week low on US biotech investment curbsHK Stock Market Update·Oct 27, 2026 at 02:25 AM01530-1.58%
3SBio hits 52-week low, declines 1% in Hong KongHK Stock Market Update·Oct 23, 2026 at 01:34 AM01530-1.58%
UBS Downgrades UNITED LAB to Neutral; Reiterates SIMCERE PHARMA as Top PickAASTOCKS News·Oct 22, 2026 at 07:45 AM01093+3.63%01177-1.20%